Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000)
- John Radford
- , Andrew Davies*
- , Guillaume Cartron
- , Franck Morschhauser
- , Gilles Salles
- , Robert Marcus
- , Michael Wenger
- , Guiyuan Lei
- , Elisabeth Wassner-Fritsch
- , Umberto Vitolo
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
118
Citations
(Scopus)